Quercetin Eases Obesity-Linked Heart Damage in Mice

A proteomics study finds the plant flavonoid reverses high-fat diet changes in cardiac proteins that drive cardiomyopathy.

Updated on Nov. 2, 2026 in Heart Disease

Close photograph of a clear glass beaker of amber liquid on a laboratory bench in warm side light, with blurred plastic tubes beside it.
Researchers reported Thursday that quercetin, a plant flavonoid, reversed high-fat-diet changes in heart proteins and eased obesity-linked cardiomyopathy in mice. AI Illustration. Upload story photo >

Researchers report that quercetin alleviated obesity-related cardiomyopathy in high-fat diet-fed mice, shifting myocardial Fabp3 and Adipoq protein levels back toward control levels. The findings were published as accepted peer-reviewed research on November 2, 2026.

Why it matters

Obesity-related heart dysfunction is driven by altered lipid and metabolic signaling in heart tissue, and this study maps which proteins are involved. Identifying specific targets such as Fabp3 and Adipoq helps clarify how a dietary compound might influence cardiac health.

The study is a mouse proteomics investigation, with 180 proteins altered by high-fat diet and 303 altered by quercetin treatment, and 35 of 36 overlapping proteins moving in opposite directions across comparisons. Whether these protein-level changes translate into comparable effects in humans has not been established.

The players

Nature

Nature is a long-established international science journal that publishes peer-reviewed research across the natural sciences.

The details

Using tandem mass tag-based cardiac proteomics, the researchers found that high-fat diet raised myocardial Fabp3 and lowered Adipoq, while quercetin restored AMPK phosphorylation and reduced PPARα expression. Quercetin also attenuated oxidative stress, inflammation, collagen deposition and cardiac dysfunction in the mice.

Timeline

  1. November 2, 2026: The study was published early as accepted peer-reviewed research.

Health Landscape

Obesity-related cardiomyopathy is increasingly studied through proteomic profiling of heart tissue, which allows researchers to track molecular changes rather than only structural damage. This quercetin study extends that approach by linking specific lipid-metabolism proteins to functional cardiac outcomes in a diet-induced model.

Because the work is limited to mice, it does not yet change how people with obesity or heart disease are treated or what supplements they should take. Readers should not interpret the findings as a reason to change their medication or diet without consulting a clinician.

The takeaway

Diet-induced heart changes involve specific shifts in lipid-handling proteins, and this study shows they can be partly reversed in mice. Human relevance remains untested, so the findings are best read as an early mechanistic step rather than practical advice.

Further reading

For related context, explore our coverage of Heart Disease.

Source note: This article includes information reported by Nature.